Sun Pharmaceutical Industries Ltd 2022 Annual Report with Sustainability Disclosures
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 324
The report describes a strong FY22, with consolidated revenues growing 15.6% to ₹ 384 Billion and EBITDA growing 23.6% to ₹ 101 Billion. Specialty products had been commercialised across markets and contributed about 13% of consolidated revenues. The report also highlights a global workforce of more than 38,000 people and newly set targets to reduce Scope 1 and Scope 2 carbon emissions by 35% by 2030, water consumption by 10% by 2025, and hazardous waste through co-processing by 2025.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.